IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Polley, R.
Right arrow Articles by Kaye, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Polley, R.
Right arrow Articles by Kaye, P. M.
Infection and Immunity, January 2006, p. 773-776, Vol. 74, No. 1
0019-9567/06/$08.00+0     doi:10.1128/IAI.74.1.773-776.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Adoptive Immunotherapy against Experimental Visceral Leishmaniasis with CD8+ T Cells Requires the Presence of Cognate Antigen

Rosalind Polley ,1,{dagger},{ddagger} Simona Stager,1,{dagger} Sara Prickett,2,|| Asher Maroof,1,§ Soombul Zubairi,1,§ Deborah F. Smith,2,§ and Paul M. Kaye1*

Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT United Kingdom,1 Wellcome Trust Laboratories for Molecular Parasitology, Department of Biological Sciences, Imperial College London, London, SW7 2AZ United Kingdom2

Received 26 July 2005/ Accepted 13 September 2005

CD8+ T cells have a protective role in experimental visceral leishmaniasis. However, the observation that inflammatory cytokines induce bystander activation of CD8+ T cells questions the need for antigen-dependent effector function. Here, we demonstrate that successful adoptive immunotherapy with CD8+ T cells is strictly dependent upon the presence of cognate antigen.


* Corresponding author. Present address: Immunology and Infection Unit, Dept. of Biology, University of York, P.O. Box 373, York, YO10 5YW United Kingdom. Phone: 44 1904 324480. Fax: 44 1904 328845. E-mail: pmk2{at}york.ac.uk.

Editor: J. L. Flynn

{dagger} These authors contributed equally to this work.

{ddagger} Present address: Lymphocyte Biology Section, Laboratory of Immunology, NIAID/National Institutes of Health, Bethesda, MD 20892.

Present address: Division of Biomedical Sciences, Johns Hopkins in Singapore, 31 Biopolis Way, 02-01 The Nanos, Singapore 138669, Republic of Singapore.

|| Present address: Division of Infection and Immunity, Walter and Eliza Hall Institute, 1G Royal Parade, Parkville, Victoria 3050, Australia.

§ Present address: Immunology and Infection Unit, Dept. of Biology, University of York, P.O. Box 373, York, YO10 5YW United Kingdom.


Infection and Immunity, January 2006, p. 773-776, Vol. 74, No. 1
0019-9567/06/$08.00+0     doi:10.1128/IAI.74.1.773-776.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2006 by the American Society for Microbiology. All rights reserved.